Voice Treatment Techniques

1998 ◽  
Vol 7 (3) ◽  
pp. 49-64 ◽  
Author(s):  
Mary Pannbacker
Keyword(s):  
Treatment Outcomes ◽  
Treatment Options ◽  
Limited Data ◽  
Future Studies ◽  
Treatment Practices ◽  
Breathing Exercises ◽  
Treatment Techniques ◽  
Voice Treatment

Clinicians are confronted with several treatment options for which there are limited data about efficacy. Some voice treatment practices have broad acceptance, whereas others, such as breathing exercises and optimum pitch, are controversial. This paper reviews what is currently known about the efficacy of voice treatment and makes recommendations for future studies of voice treatment outcomes and efficacy.

The Use of Optimized ERW Technique to Improve Low Temperature Fracture Toughness of Welded Pipes

2020 ◽  
Author(s):  
Muhammad Rashid ◽  
Timothy Hylton ◽  
Neil Anderson ◽  
Laurie Collins ◽  
Leijun Li
Keyword(s):  
Heat Treatment ◽  
Fracture Toughness ◽  
Low Temperature ◽  
Weld Seam ◽  
Peak Temperature ◽  
Line Pipe ◽  
Squeeze Pressure ◽  
Treatment Practices ◽  
Treatment Techniques ◽  
Research Activities

Abstract It is understood that the bondline microstructure of the line pipe ERW seam can be a zone of weakness in the pipe. To overcome this weakness, several research projects utilizing various line pipe steel grades and welding and heat treatment techniques have been conducted at EVRAZ NA. The overall goal of these efforts has been to understand the development of bondline microstructure during the ERW process and improve the weld seam fracture toughness for low temperature applications. These research activities included mill trials and Gleeble simulations. It was realized that a high toughness ERW weld seam is only possible through a tightly controlled combination of weld power, forging (squeeze) pressure, and welding speed. Research studies have indicated that the as-welded seam may not pass the standard ERW destructive tests if proper heat input and adequate squeeze pressure are not applied. Post weld heat treatment (normalizing) practice was also found to be a key element in the development of the appropriate bondline microstructure for higher toughness. Samples from pipes normalized using different heat treatment practices produced different bondline microstructures and hence different toughness properties. It was found through this study that a low (but still higher than the upper critical temperature Ac3) normalizing peak temperature and adequate soak time at the peak temperature result in improved Charpy toughness of ERW bondline microstructure.

An update on the treatment of cutaneous tumours

UK-Vet Equine ◽  
2021 ◽  
Vol 5 (6) ◽  
pp. 247-252
Author(s):  
Anna Hollis
Keyword(s):  
Treatment Options ◽  
Surgical Excision ◽  
Careful Consideration ◽  
Limited Data ◽  
Clinical Appearance ◽  
Clinical Challenge ◽  
Number Of Factors ◽  
Intralesional Treatment ◽  
New Treatment ◽  
Number Of Treatment

Cutaneous tumours continue to present a significant clinical challenge in equine practice. There are a large number of treatment options and selecting the appropriate modality requires careful consideration of a number of factors. While sarcoids are the most commonly diagnosed cutaneous tumour, their clinical appearance can have considerable overlap with other types of lesion, so biopsy should be performed where the diagnosis is uncertain. New treatment options for sarcoids include electrosurgery, electrochemotherapy and novel intralesional treatments. Melanomas still have relatively limited treatment options beyond surgical resection, but there are now limited data to support the use of a xenogenic DNA vaccination protocol. Squamous cell carcinomas are generally best treated via surgical excision, but a novel intralesional treatment may prove to be a useful option for further treatment.

scholarly journals TREATMENT OPTIONS FOR NEGLECTED ACHILLES TENDON RUPTURED: WETHER SPONTANEOUS HEALING IS POSSIBLE?

2018 ◽  
Vol 24 (2) ◽  
pp. 59-69
Author(s):  
A. P. Sereda
Keyword(s):  
Surgical Treatment ◽  
Achilles Tendon ◽  
Treatment Outcomes ◽  
Plantar Flexion ◽  
Treatment Options ◽  
Tendon Healing ◽  
Spontaneous Healing ◽  
Minimal Incision ◽  
Better Than

The paper considers cases of spontaneous healing of achilles tendon with elongation. In such condition the tendon defect is not palpable, active plantar flexion is preserved and patients are complaining for strength diminution.Purpose— to study features of spontaneous achilles tendon healing with elongation and to analyze the shortening tenoplasty option as a procedure primarily aimed at restoration of strength for gastrocnemius-soleus complex.Material and Methods.The paper presents features and outcomes of surgical treatment of 25 patients who underwent a shortening tenoplasty of various types: crimping (3 patients), Z-type (2 patients), oblique (1 patient) and transverse (19 patients).Results.No re-ruptures or other serious complications were observed in the patients of the present study. Treatment outcomes were evaluated by j. leppilahti scale in 304,7±8,9 days after the procedure. postoperative leppilahti scores were statistically significantly better than prior to surgery — 82,4±5,6 and 62,2±7,7, respectively, (p<0,0001). Conclusion. Shortening tenoplasty can be indicated in cases of spontaneous achilles tendon healing with elongation. at relatively early stages of the injury with rather elastic scars the crimping tenoplasty can be applied.  At later stages a resection shortening tenoplasty is recommended through a minimal incision with transverse resection of tendon and removal of scar block. 

scholarly journals Nasobiliary Drain Diverted through a Percutaneous Endoscopic Gastrostomy Tube: A Novel Approach to Nasobiliary Drainage

2021 ◽  
pp. 891-897
Author(s):  
Nikolaos Dimitrios Pantzaris ◽  
Tim Lord ◽  
Robyn Sotheran ◽  
John Hutchinson ◽  
Charles Millson
Keyword(s):  
Percutaneous Endoscopic Gastrostomy ◽  
Treatment Options ◽  
Primary Biliary Cholangitis ◽  
Percutaneous Endoscopic Gastrostomy Tube ◽  
Limited Data ◽  
Endoscopic Gastrostomy ◽  
Novel Approach ◽  
Nasobiliary Drainage ◽  
Uvb Phototherapy

Intractable pruritus is a common, debilitating symptom and a well-defined entity occurring in chronic cholestatic disorders. Treatment options include cholestyramine, rifampicin, naltrexone, gabapentin, and sertraline, as well as more interventional measures, such as plasmapheresis, extracorporeal albumin dialysis, nasobiliary drains (NBDs), and UVB phototherapy in patients who fail to respond to medical therapy. Despite the limited data, NBD seems to be a highly effective treatment in the relief of refractory cholestatic pruritus. In this article, we present the case of a 73-year-old woman with primary biliary cholangitis and intractable pruritus, refractory to medical treatment. The patient had a complete resolution of her symptoms following an NBD placement, in which, with a novel approach, the nasal end was redirected and exited through a percutaneous endoscopic gastrostomy port, significantly improving her quality of life.

Comprehensive Treatment of Dactylitis in Psoriatic Arthritis

2014 ◽  
Vol 41 (11) ◽  
pp. 2295-2300 ◽  
Author(s):  
Shawn Rose ◽  
Sergio Toloza ◽  
Wilson Bautista-Molano ◽  
Philip S. Helliwell
Keyword(s):  
Psoriatic Arthritis ◽  
Primary Outcome ◽  
Treatment Options ◽  
Current Treatment ◽  
Nonsteroidal Antiinflammatory Drugs ◽  
Clinical Feature ◽  
Comprehensive Treatment ◽  
Limited Data ◽  
Disease Modifying Antirheumatic Drugs ◽  
Antiinflammatory Drugs

Dactylitis, a hallmark clinical feature of psoriatic arthritis (PsA) and other spondyloarthropathies, may also be a severity marker for PsA and psoriasis. Traditionally, clinicians have used nonsteroidal antiinflammatory drugs and local corticosteroid injections to treat dactylitis, although conventional disease-modifying antirheumatic drugs are also used. We performed a systematic literature review to determine the most efficacious current treatment options for dactylitis in PsA. Effect sizes were greatest for the biologic agents ustekinumab, certolizumab, and infliximab, suggesting that therapy with one of these agents should be initiated in patients with dactylitis. However, the limited data highlight the need for randomized, placebo-controlled trials, with dactylitis as a primary outcome, to determine a valid, reliable, and responsive clinical outcome measure for PsA patients with dactylitis.

Pharmacotherapy review: Emerging treatment modalities in transthyretin cardiac amyloidosis

2021 ◽  
Author(s):  
Emily Plumadore ◽  
Lindsay Lombardo ◽  
Katherine P Cabral
Keyword(s):  
Treatment Options ◽  
Disease State ◽  
Treatment Modalities ◽  
Limited Data ◽  
Limited Evidence ◽  
Agent Selection ◽  
Selection For ◽  
Tea Extract

Abstract Disclaimer In an effort to expedite the publication of articles , AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose This review aims to summarize the evidence and pharmacological characteristics of treatment options for transthyretin amyloid cardiomyopathy (ATTR-CM). Additionally, this review highlights the role of clinical pharmacists in helping to secure newly introduced therapies. Summary ATTR-CM, a disease characterized by misfolded protein that is deposited in the myocardium and disrupts cardiac functioning, has historically been underdiagnosed due to the need for invasive biopsy and an illusion of rarity. Once diagnosed, limited treatment modalities for ATTR-CM have led providers to rely on nonpharmacological remedies or off-label use of medications with limited evidence of benefit. However, recent noninvasive diagnostic advancements and heightened disease state awareness have revealed increased prevalence of ATTR-CM. This has led to the introduction of several first-in-class pharmaceuticals with actions targeted at inhibiting the various phases of amyloidosis: TTR stabilizers include diflunisal and first-in-class, Food and Drug Administration (FDA)-approved tafamidis; TTR silencers include patisiran and inotersen; fibril disrupters include doxycycline with tauroursodeoxycholic acid; and alternative agents include green tea extract and curcumin. Conclusion ATTR-CM treatments have emerged and, despite current limited data, are continuing to evolve. Tafamidis, the only agent approved by FDA for ATTR-CM, shows promise to improve survival and quality of life in patients with ATTR-CM. Pharmacists can play a key role in assisting with agent selection for this disease state, as well as providing knowledge about current and future clinical trials evaluating the safety and efficacy of the available treatment modalities.

Persistent Genital Arousal Disorder

2016 ◽  
pp. 109-123 ◽  
Author(s):  
David Goldmeier ◽  
Shalini Andrews
Keyword(s):  
Successful Treatment ◽  
Sexual Desire ◽  
Treatment Options ◽  
Physiological Arousal ◽  
Limited Data ◽  
Genital Arousal ◽  
Arousal Disorder ◽  
Common Etiology ◽  
Uncertain Etiology

Persistent genital arousal disorder (PGAD) is a newly recognized condition of uncertain etiology with limited data on successful treatment. It best can be described as persistent physiological arousal in the absence of conscious feelings of sexual desire. PGAD consists of extended periods of sexual excitement that neither diminish on their own nor resolve with ordinary orgasmic experiences. The arousal is distressing, unwanted, and often painful. The majority of PGAD cases have been identified in women. Although the disorder can occur in men, there is no data on prevalence in men and little is known about whether or not there a common etiology is shared with female cases of PGAD. The chapter ends by discussing several possible etiologies and four main treatment options.

A survey of speech-language pathology treatment for non-progressive dysarthria in Australia

2020 ◽  
Vol 21 (2) ◽  
pp. 173-190
Author(s):  
Narissa Gracia ◽  
Anna F. Rumbach ◽  
Emma Finch
Keyword(s):  
Online Survey ◽  
Management Practices ◽  
High Tech ◽  
Functional Communication ◽  
Treatment Techniques ◽  
Voice Treatment ◽  
Language Pathology ◽  
Treatment Context ◽  
Oral Motor Exercises ◽  
Almost All

AbstractAim:To identify management practices of Australian speech-language pathologists (SLPs) in the treatment of non-progressive dysarthria using a subsystem approach, and to explore SLPs’ consideration and implementation of the theoretical underpinnings of non-progressive dysarthria management.Method:A 39-item online survey was distributed to Australian SLPs, with 80 responses suitable for data analysis.Results:Practices of SLPs were variable for the management of the speech subsystems. The Lee Silverman Voice Treatment (LSVT®) was the most commonly used manualised treatment program, and was employed by 63.77% of respondents. Almost all SLPs (>88%) provided strategies to improve functional communication. There was no clear preference for low tech alternative and augmentative communication (AAC) devices. Speech generating devices were the most commonly employed high tech device. Almost two-thirds of respondents used non-speech oral motor exercises (NSOMEs) in treatment. SLPs had varied frequencies and models of service delivery for intervention. SLPs valued interventions targeting the activity and participation domains of the ICF, however this was restricted by the treatment context and resources available. The majority of SLPs (92.06%) were aware of the principles of motor learning, however many were unsure regarding the specifics of implementation.Conclusion:There is a clear need for further research into the efficacy of treatment techniques to guide decision-making.

scholarly journals Pathogenesis and radiobiology of brain arteriovenous malformations: implications for risk stratification in natural history and posttreatment course

2009 ◽  
Vol 26 (5) ◽  
pp. E9 ◽  
Author(s):  
Achal S. Achrol ◽  
Raphael Guzman ◽  
Monika Varga ◽  
John R. Adler ◽  
Gary K. Steinberg ◽  
...  
Keyword(s):  
Natural History ◽  
Arteriovenous Malformations ◽  
De Novo ◽  
Genetic Disorders ◽  
Treatment Options ◽  
Latency Period ◽  
Endovascular Embolization ◽  
Future Studies ◽  
Brain Arteriovenous Malformations ◽  
Congenital Origin

Brain arteriovenous malformations (BAVMs) are an important cause of intracerebral hemorrhage (ICH) in young adults. Biological predictors of future ICH risk are lacking, and controversy exists over previous studies of natural history risk among predominantly ruptured BAVM cohorts. Recent studies have suggested that the majority of BAVMs are now diagnosed as unruptured lesions, and that the risk according to natural history among these lesions may be less than previously assumed. In the first part of this review, the authors discuss available data on the natural history of BAVMs and highlight the need for future studies that aim to develop surrogate biomarkers of disease progression that accurately predict future risk of ICH in BAVMs. The etiology of BAVM remains unknown. Recent studies have suggested a role for genetic factors in the pathogenesis of sporadic BAVM, which is further supported by reports of familial occurrence of BAVM and association with known systemic genetic disorders (such as Osler-Weber-Rendu disease, Sturge-Weber disease, and Wyburn-Mason syndrome). Molecular characterization of BAVM tissue demonstrates a highly angiogenic milieu with evidence of increased endothelial cell turnover. Taken together with a number of reports of de novo BAVM formation, radiographic growth after initial BAVM diagnosis, and regrowth after successful treatment of BAVM, these findings challenge the long-held assumption that BAVMs are static lesions of congenital origin. In the second part of this review, the authors discuss available data on the origins of BAVM and offer insights into future investigations into genetics and endothelial progenitor cell involvement in the pathogenesis of BAVM. Current treatment options for BAVM focus on removal or obliteration of the lesion in an attempt to protect against future ICH risk, including microsurgical resection, endovascular embolization, and stereotactic radiosurgery (SRS). In the third part of this review, the authors discuss available data on SRS in BAVMs and highlight the need for future studies on the radiobiology of BAVMs, especially in regard to biomarker detection for tracking SRS response during the latency period. Insights from future investigations in BAVM may not only prove important for the development of novel therapies and relevant biomarkers for BAVM, but could also potentially benefit a variety of other disorders involving new vessel formation in the CNS, including stroke, tumors, moyamoya disease, and other cerebrovascular malformations.

IPIECA/OGP GUIDE TO OILED SHORELINE OILING ASSESSMENT (SCAT) SURVEYS

2014 ◽  
Vol 2014 (1) ◽  
pp. 299649 ◽  
Author(s):  
Edward Owens ◽  
Helen Dubach
Keyword(s):  
Data Base ◽  
Information Needs ◽  
Treatment Options ◽  
Implementation Process ◽  
Initial Response ◽  
Decision Makers ◽  
Data Generation ◽  
Design Elements ◽  
Assessment Program ◽  
Treatment Techniques

This new IPIECA/OGP Guide explains why and how an effective oiled shoreline assessment program is necessary and appropriate to support the planning, decisions making and implementation process for a shoreline response for the initial response to the completion of treatment o cleanup operations. Some of the key elements of the Guide include:• how a SCAT Programme fits into the Shoreline Response Programme and is vertically and horizontally integrated within the response management organization;• how the key components of a shoreline assessment program are integrated into the data generation, decision process, and implementation and closure stages of a shoreline response• the importance of segmentation, as part of pre-spill planning when possible, to divide the shoreline into operational working units and as the foundation for a data base;• identification of the information needs, and expectations, of the decision makers and the flow of information from the documentation generated by the field teams, through the data base, to support the development of treatment options and constraints, treatment end points, and finally into the inspection and closure process;• types of data (maps, tables, reports etc.) that are generated;• lines of communication and support for field Operations regarding (a) guidelines for treatment techniques and strategies, (b) operational environmental, cultural and socioeconomic limitations, (c) treatment priorities, and (d) the application and understanding of Shoreline Treatment Recommendations (STRs) (the shoreline treatment “work orders”);• participants and design elements of a Shoreline Assessment Programme Plan and ;• checklists for the key participants of a SCAT Programme (SCAT Coordinator, Field Team Leads, SCAT-OPS Liaison, Logistics Coordinator, and SCAT Data Manager) for each of the initial (“reactive”) planning, and completion (“closure”) phases of a typical response operation. The SCAT process provides a strategy for completion without which a spill response would be unable to ensure a timely end, which may lead to misuse of resources and negative environmental impacts due to excessive treatment. Shoreline assessment surveys provide valuable information and support for decision makers, planners and operations, no matter the size of the spill, the scale of the response or the environmental setting, to effectively treat or clean oiled shorelines by accelerating recovery without causing additional harm to the environment.

Sign in / Sign up

Export Citation Format

Share Document